Lineage Cell Therapeutics, Inc.
NYSE · Healthcare · Biological Products, (No Diagnostic Substances) · Carlsbad, CA
LCTX chart
What traders are saying about $LCTX
Latest postsLineage Cell Therapeutics, Inc. news
- Lineage Cell Therapeutics, Inc. Estimates – AMEX:LCTX
TradingView ·
- 3 Small Cap Stocks With Strong Revenue Growth And Low Debt
Yahoo Finance ·
- Lineage Cell Therapeutics Announces Issuance of Patent Underlying Its AlloSCOPE™ 5D Manufacturing Platform
Yahoo Finance ·
- Lineage Cell Therapeutics (LCTX) Q2 2026 Earnings Call Transcript
fool.com ·
- Lineage Cell Therapeutics Q2 Earnings Call Highlights
marketbeat.com ·
- Lineage Cell Therapeutics, Inc. Q2 2026 Earnings Call Summary
app.moby.co ·
- Lineage Cell Therapeutics Inc (LCTX) (Q2 2026) Earnings Call Highlights: Cash Runway Extended, ...
Yahoo Finance ·
- Lineage Cell (LCTX) Reports Q2 Loss, Lags Revenue Estimates
Yahoo Finance ·
- Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Yahoo Finance ·
- Lineage Cell Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 6, 2026
Yahoo Finance ·
- Lineage Cell Therapeutics Maps COR1 Path With ‘Thaw and Inject’ Cell Therapy Plan
marketbeat.com ·
- Lineage Provides Update on COR1 Cell Therapy Program for Corneal Endothelial Disease
Yahoo Finance ·
Lineage Cell Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $14.6M | $9.5M | $8.9M | $14.7M |
| Net income | -$63.5M | -$18.6M | -$21.5M | -$26.3M |
| Diluted EPS | $-0.28 | $-0.09 | $-0.12 | $-0.15 |
| Total assets (year end) | $112.6M | $113.2M | $101.0M | $123.7M |
| Cash and equivalents (year end) | $40.8M | $45.8M | $35.4M | $11.4M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Lineage Cell Therapeutics, Inc.
- Ticker
- LCTX (NYSE)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Carlsbad, CA
- Incorporated in
- CA
- Fiscal year end
- December 31
- SEC CIK
- 876343
- Former names
- BIOTIME INC
Frequently asked questions
What exchange is Lineage Cell Therapeutics, Inc. listed on?
Lineage Cell Therapeutics, Inc. trades on the NYSE under the ticker symbol LCTX.
What industry is Lineage Cell Therapeutics, Inc. in?
Lineage Cell Therapeutics, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Lineage Cell Therapeutics, Inc. headquartered?
Lineage Cell Therapeutics, Inc.'s business address on file with the SEC is in Carlsbad, CA.
When does Lineage Cell Therapeutics, Inc.'s fiscal year end?
Lineage Cell Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Lineage Cell Therapeutics, Inc. report?
Lineage Cell Therapeutics, Inc. reported $14.6M in revenue for calendar year 2025, according to its SEC filings.